Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Tenet outperforms in Q4, projects solid 2026 amid ACA disruption
The hospital and ASC chain said it expects earnings growth to continue in 2026 despite a $250 million hit to adjusted EBITDA from expired subsidies.
Dave Muoio
Feb 11, 2026 3:00pm
Sponsored
Empowering Patients with a Best-in-Class Care Team
Feb 9, 2026 8:00am
500M records exchanged through TEFCA, HHS IT arm boasts
Feb 11, 2026 12:42pm
Sponsored
'Coding Intensity' Is Ending. 'Defensible Accuracy' Is Here.
Feb 9, 2026 8:00am
Humana CEO: Insurer is ready to adapt if 2027 MA rates stay flat
Feb 11, 2026 12:30pm
Bringing down costs in dermatology
Feb 11, 2026 9:22am
More News
Oscar posts $443M 2025 loss but is on path to 2026 profitability
Feb 10, 2026 3:50pm
Healthcare Dealmakers—OpenAI's health startup pickup and more
Feb 10, 2026 3:30pm
CVS CEO Joyner calls 2027 MA rate notice 'disappointing'
Feb 10, 2026 1:00pm
House Republicans subpoena 8 insurers over ACA fraud measures
Feb 10, 2026 12:30pm